UBS is bullish on Ceres, if the fuel cell firm can land at least one new partner

UBS reiterated a Buy on Ceres Power with a 570p price target after a roadshow with CFO Stuart Paynter, citing accelerating licence signings, expanded access to the US power market and partner-driven reductions in system costs for its solid oxide fuel cell technology. The broker sees material upside if partners scale to multiple gigawatts and reiterated management’s view that Ceres can reach EBITDA and cash breakeven in 2026, conditional on securing at least one additional licence partner, with strong IP protections under the Weichai agreement supporting the thesis.

Analysis

Market structure: Ceres' licence-led scaling (vs. capital-heavy manufacturing) benefits Ceres (LSE:CWR) equity, OEM licence partners and suppliers of SOFC-specific ceramics/ni-based anodes; incumbents in gas peaking and some battery storage providers face longer-term volume risk if SOFCs reach multi‑GW cost parity. If one partner signs and targets >100MW/year within 12–24 months, expect downward pressure on levelized cost of firm low‑carbon power by 20–30% vs today, improving Ceres’ pricing power but compressing vendor margins downstream.

Risk assessment: Primary tail risks are partner execution failure, stack durability shortfalls and US policy/headwind (Buy‑America or interconnection delays) — each can flip a 2026 breakeven thesis to cash burn. Near-term (0–3 months) volatility will be driven by partner announcements; medium-term (3–12 months) by demonstration/system cost metrics; long-term (2–5 years) by multi‑GW scaling and supply‑chain inputs (zirconia/ni prices, skilled manufacturing).

Trade implications: Tactical play is asymmetric—buy optionality into a partner announcement. Use a small core equity position (2–3% portfolio) in CWR and 6–9 month call spreads to capture binary upside; consider a relative short versus Bloom Energy (BE) to express licensing advantage. Rotate modestly away (1–3% underweight) from pure peaker operators exposed to merchant capacity risk (eg, NRG) into modular fuel‑cell suppliers and integrators.

Contrarian angles: Consensus may under-price partner concentration and over‑credit IP fences — a single partner reduces risk but also concentrates execution and margin exposure. Historical analogs (ARM licences vs. proprietary manufacturers) show licensing can re‑rate quickly once multi‑partner scale is visible; conversely, failure to land a partner within 12 months should trigger a >30% re‑rating lower.

Key Decisions for Investors

• Consider establishing a 2–3% long position in Ceres Power (LSE:CWR, OTC:CPWHF) immediately to capture upside from licence momentum; plan to scale to 5–7% on confirmation of at least one new licence partner within 3–6 months. Use a hard stop at -30% or exit if no partner is signed within 12 months.
• Implement a 6–9 month call spread on CWR (buy ~25‑delta call, sell ~10% OTM call) sized to 1–2% of portfolio to capture the binary partner announcement upside while capping cost; target >40% gross return if price re-rates to UBS 570p PT.
• Enter a pair trade: long CWR (notional 1–2%) vs short Bloom Energy (BE) (equal notional), expressing licensing model advantage and lower capex exposure; reassess after 6 months or at any announced partner MoU.
• Reduce exposure by 1–3% to merchant peaker‑exposed IPPs (eg, NRG) over next 3 months and redeploy into modular low‑carbon generator suppliers if Ceres announces US market entry/DoE grant within 90 days; if no US traction within 6 months, reverse allocation.